NSK-B-CE Newborn Screening

Krista Backiel is responsible for managing and promoting products that are utilized in metabolomics and clinical/diagnostic MS. She spends a lot of her time developing new products to assist customers in their diverse research efforts.

Krista Backiel oversees all market development and promotional activities for CIL’s products with a focus in the metabolomics and clinical/diagnostic MS markets. She spends a lot of her time developing new products to assist customers in their diverse research efforts. She has been with CIL since 2005 and has held many different positions within the Sales and Marketing team since then. She has a BS in biology and biotechnology from Worcester Polytechnic Institute and an MBA with concentrations in health sector management and marketing from Boston University. In her free time, Krista likes to travel, cook, play soccer, and ride her bike!

Dr. Andrew Percy is the Senior Applications Chemist for Mass Spectrometry and the MS ‘Omics Product Manager at CIL. His responsibilities minimally involve providing technical support, overseeing product development, identifying new product market opportunities, assisting in the analysis of product-related applications, and writing/reviewing marketing literature.

Dr. Andrew Percy is the Senior Applications Chemist for Mass Spectrometry and the MS ‘Omics Product Manager at CIL. His responsibilities minimally involve providing technical support, overseeing product development, identifying new product market opportunities, assisting in the analysis of product-related applications, and writing/reviewing marketing literature.

Andrew has been in the MS field for more than 15 years. He obtained a PhD in bioanalytical chemistry at the University of Calgary (Alberta, Canada) in 2011. After a brief postdoctoral fellowship in 2011, he became the Quantitative Proteomics group leader at the UVic-Genome BC Proteomics Centre (BC, Canada). His research there focused on the development and application of novel MS-based assays for the qualification/quantification of proteins in human and mouse biosamples. He held this position until joining CIL in early 2016. At CIL he leverages his expertise with MS and isotopically labeled analytes to facilitate product analysis and internal developments, as well as assisting customers with product applications in a diverse range of research avenues. To date, Dr. Percy has published more than 40 research articles in peer-reviewed journals; he is an active member of the mQACC consortium, acts as an ad-hoc reviewer for an array of scientific journals, and is on the editorial board of Biomedicines.